Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial

被引：0
|
作者：
Villa, Diego [1 ]
Larouche, Jean-Francois [2 ]
Cheung, Matthew C. [3 ]
Keating, Mary-Margaret [4 ]
Zukotynski, Katherine [5 ,6 ]
Tonseth, Petter [7 ]
Mayo, Samantha [8 ]
Laister, Robert [9 ]
Scott, David W. [10 ]
Kuruvilla, John [11 ]
机构：
[1] BC Canc, Ctr Lymphoid Canc, Vancouver, BC, Canada
[2] Ctr Hosp Univ Quebec, Hop Enfant Jesus, Quebec City, PQ, Canada
[3] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[4] Queen Elizabeth II QEII Hlth Sci Ctr, Halifax, NS, Canada
[5] McMaster Univ, Dept Radiol, Hamilton, ON, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] BC Canc, Dept Funct Imaging, Vancouver, BC, Canada
[8] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[9] Princess Margaret Canc Ctr, Toronto, ON, Canada
[10] BC Canc, Vancouver, BC, Canada
[11] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma
    Kang, T. Y.
    Rybicki, L. A.
    Bolwell, B. J.
    Thakkar, S. G.
    Brown, S.
    Dean, R.
    Sekeres, M. A.
    Advani, A.
    Sobecks, R.
    Kalaycio, M.
    Pohlman, B.
    Sweetenham, J. W.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 973 - 978
  • [42] Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma
    Romancik, Jason T.
    Allen, Pamela B.
    Waller, Edmund K.
    Chen, Zhengjia
    Valla, Kelly
    Dixon, Kaylan
    Reagan, David J.
    Colbert, Amanda B.
    Rosand, Cecilia
    Palmer, Alexandra
    Flowers, Christopher
    Cohen, Jonathon B.
    BLOOD, 2020, 136
  • [43] Rituximab and stem cell transplantation produces durable remissions in mantle cell lymphoma.
    Capote, FJ
    Pascual, MJ
    Gonzalez-Barca, E
    Bergua, JM
    Jimenez, A
    Romero, A
    Garcia-Boyero, R
    Giraldo, P
    Fernandez-Calvo, J
    Ribera, JM
    Ramirez, MJ
    Amigo, ML
    Munoz, MI
    Caballero, D
    Guinot, M
    Oriol, A
    Moraleda, JM
    Palomera, L
    Almagro, M
    Leon, A
    Fernandez-de Sevilla, A
    Gil, JL
    BLOOD, 2004, 104 (11) : 390A - 390A
  • [44] RITUXIMAB MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION PROLONGS PROGRESSION FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA
    Dietrich, S.
    Weidle, J.
    Meissner, J.
    Radujkovic, A.
    Ho, A.
    Dreger, P.
    Witzens-Harig, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S180 - S181
  • [45] Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation Prolongs Progression Free Survival In Patients With Mantle Cell Lymphoma
    Dietrich, Sascha
    Weidle, Julia
    Meissner, Julia
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Witzens-Harig, Mathias
    BLOOD, 2013, 122 (21)
  • [46] Addition of rituximab to TBI/CY improves the outcome of first-line autologous stem cell transplantation for mantle cell lymphoma
    Seyfarth, B
    Boehme, V
    Stuhlmann, R
    Sonnen, R
    Kneba, M
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S6 - S6
  • [47] Intensive chemotherapy and autologous stem cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle cell lymphoma: A matched pair analysis.
    Mangel, J
    Leitch, HA
    Connors, JM
    Buckstein, R
    Imrie, K
    Spaner, D
    Berinstein, NL
    BLOOD, 2002, 100 (11) : 780A - 780A
  • [48] Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era
    Tam, Constantine S.
    Herschtal, Alan
    Dickinson, Michael
    George, Anupkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3166 - 3167
  • [49] The unfavourable clinical outcome of mantle cell lymphoma is not improved by high-dose chemotherapy and autologous stem cell transplantation
    Van de Velde, AL
    Gadisseur, AP
    Steel, E
    Van Steenweghen, S
    Schroyens, W
    Berneman, ZN
    Zachee, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S350 - S350
  • [50] Outcomes after autologous stem cell transplantation for mantle cell lymphoma based on remission status and induction chemotherapy regimen
    Till, Brian G.
    Gooley, Theodore A.
    Crawford, Nathan
    Gopal, Ajay K.
    Maloney, David G.
    Petersdorf, Stephen H.
    Pagel, John M.
    Holmberg, Leona
    Bensinger, William
    Press, Oliver W.
    BLOOD, 2007, 110 (11) : 566A - 566A
12345